SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms
16 references·0 citing·46 second hop
Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms (2018)Differentiation of innovation strategies …Being central is a double-edged sword: Knowledge network centrality and new product development in U.S. pharmaceutical industry (2016)Being central is a double-edg…Anticipation of converging technology areas — A refined approach for the identification of attractive fields of innovation (2016)Anticipation of converging te…The Role of Growth Options in Explaining Stock Returns (2014)The Role of Growth Options in…Innovating the innovation process: an organisational experiment in global pharma pursuing radical innovation (2014)Innovating the innovation pro…Influence of government R&D support and inter-firm collaborations on innovation in Korean biotechnology SMEs (2011)Influence of government R&D s…Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs (2010)Trends in Risks Associated Wi…Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis (2010)Organisational modes for Open…Knowledge arbitrage in global pharma: a synthetic view of absorptive capacity and open innovation (2010)Knowledge arbitrage in global…Is open innovation the way forward for big pharma? (2010)Is open innovation the way fo…Open R&D and open innovation: exploring the phenomenon (2009)Open R&D and open innovation:…Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms (2007)Life Science Innovation and t…Analysing the link between export intensity, innovation and firm size in a science-based industry (2007)Analysing the link between ex…Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks (2006)Inter-firm R&D partnering in …Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers (2005)Organizing Pharmaceutical Inn…The Era of Open Innovation (2003)The Era of Open InnovationTechnological change and network dynamics (2001)Technological change and netw…Economic Welfare and the Allocation of Resources for Invention (1962)Innovation and Learning: The Two Faces of R & D (1989)Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)Knowledge Specialization, Organizational Coupling, and the Boundaries of the Firm: Why Do Firms Know More than They Make? (2001)Sectoral systems of innovation and production (2002)Network Dynamics and Field Evolution: The Growth of Interorganizational Collaboration in the Life Sciences (2005)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Do government grants promote innovation efficiency in China's high-tech industries? (2016)Identifying enablers of technological innovation for Indian MSMEs using best–worst multi criteria decision making method (2016)Does intellectual capital allow improving innovation performance? A quantitative analysis in the SME context (2017)Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms (2005)Open innovation : researching a new paradigm (2006)Leveraging External Sources of Innovation: A Review of Research on Open Innovation (2013)Open innovation: The next decade (2014)A Bibliometric Review of Open Innovation: Setting a Research Agenda (2016)Case Study Research: Design and Methods (1984)Open Innovation in Practice: An Analysis of Strategic Approaches to Technology Transactions (2008)WHY 'OPEN INNOVATION' IS OLD WINE IN NEW BOTTLES (2009)The Strength of Weak Ties (1973)Exploration and Exploitation in Organizational Learning (1991)Creating and Capturing Value (2010)Open innovation: State of the art and future perspectives (2010)The role of digital technologies in open innovation processes: an exploratory multiple case study analysis (2018)Structural equation modeling in practice: A review and recommended two-step approach. (1988)Assessing the impact of organizational learning capability on product innovation performance: An empirical test (2007)Knowledge management and innovation performance in a high-tech SMEs industry (2011)Organizational innovation, technological innovation, and export performance: The effects of innovation radicalness and extensiveness (2016)The price of innovation: new estimates of drug development costs (2003)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Open Innovation: The New Imperative for Creating and Profiting from Technology (2004)Wikinomics: how mass collaboration changes everything (2007)Open science is a research accelerator (2011)The Pharmaceutical Commons (2014)Sources of Information as Determinants of Product and Process Innovation (2016)Capitalism, Socialism and Democracy (1997)The Theory of Economic Development (2003)Managing open innovation projects with science-based and market-based partners (2014)Changing R&D models in research-based pharmaceutical companies (2016)The Power of Innomediation (2003)Beyond high tech: early adopters of open innovation in other industries (2006)
this work references cited by second hop

References

  • 2003The Era of Open Innovation2,784 cited
  • 2009Open R&D and open innovation: exploring the phenomenon1,835 cited
  • 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs847 cited
  • 2010Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis492 cited
  • 2011Influence of government R&D support and inter-firm collaborations on innovation in Korean biotechnology SMEs423 cited
  • 2007Analysing the link between export intensity, innovation and firm size in a science-based industry421 cited
  • 2001Technological change and network dynamics421 cited
  • 2006Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks311 cited
  • 2005Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers166 cited
  • 2010Is open innovation the way forward for big pharma?159 cited
  • 2010Knowledge arbitrage in global pharma: a synthetic view of absorptive capacity and open innovation136 cited
  • 2016Being central is a double-edged sword: Knowledge network centrality and new product development in U.S. pharmaceutical industry106 cited
  • 2016Anticipation of converging technology areas — A refined approach for the identification of attractive fields of innovation104 cited
  • 2007

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms
89 cited
  • 2014The Role of Growth Options in Explaining Stock Returns83 cited
  • 2014Innovating the innovation process: an organisational experiment in global pharma pursuing radical innovation63 cited
  • Cited by

    No citing works inside the corpus for this window.